GCM
HRMY icon

Graham Capital Management’s Harmony Biosciences HRMY Stock Holding History

Graham Capital Management’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$422K Sell
11,599
-166
-1% -$5.24K 0.01% 770
2026
Q1 		$330K Buy
11,765
+6,420
+120% +$211K 0.01% 783
2025
Q4 		$200K Sell
5,345
-5,032
-48% -$165K ﹤0.01% 1044
2025
Q3 		$286K Sell
10,377
-2,471
-19% -$85.1K ﹤0.01% 885
2025
Q2 		$406K Sell
12,848
-3,467
-21% -$112K 0.01% 900
2025
Q1 		$541K Buy
16,315
+1,625
+11% +$58.3K 0.01% 770
2024
Q4 		$505K Buy
+14,690
New +$505K 0.01% 733
2024
Q3 		– Sell
-10,523
Closed -$317K – 1195
2024
Q2 		$317K Sell
10,523
-15,241
-59% -$458K 0.01% 714
2024
Q1 		$865K Buy
+25,764
New +$827K 0.02% 464
2023
Q3 		– Sell
-14,585
Closed -$513K – 1139
2023
Q2 		$513K Sell
14,585
-103,548
-88% -$3.57M 0.01% 550
2023
Q1 		$3.86M Buy
118,133
+85,405
+261% +$3.89M 0.12% 118
2022
Q4 		$1.8M Buy
32,728
+15,529
+90% +$854K 0.05% 319
2022
Q3 		$761K Buy
+17,199
New +$839K 0.03% 598
2022
Q2 		– Sell
-6,166
Closed -$299K – 1119
2022
Q1 		$299K Buy
+6,166
New +$251K 0.01% 733

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Graham Capital Management's HRMY Position: Q2 2026 in Review

Graham Capital Management reduced its Harmony Biosciences (HRMY) stake by 1.4% in Q2 2026, selling an estimated $5.24K and leaving 11,599 shares worth $422K. The position accounts for 0.01% of the portfolio, ranked #770.

Graham Capital Management first reported a position in HRMY in Q1 2022 and has held it in 14 quarters since. The position peaked at $3.86M in Q1 2023. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Graham Capital Management held 11,599 shares of Harmony Biosciences worth $422K as of Q2 2026.
  • Graham Capital Management sold 166 Harmony Biosciences shares in Q2 2026, an estimated $5.24K.
  • Harmony Biosciences made up 0.01% of Graham Capital Management's portfolio in Q2 2026, its #770 holding.
  • Graham Capital Management first reported a position in Harmony Biosciences in Q1 2022 and has held it in 14 quarters since.
  • Graham Capital Management's Harmony Biosciences position peaked at $3.86M in Q1 2023.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Graham Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.